Japan, March 26 -- IMMUNITYBIO INC has got intellectual property rights for 'MODIFIED NK-92 CELLS FOR TREATING CANCER.' Other related details are as follows:
Application Number: JP,2023-025723
Category (FI): A61K35/17,A61K38/20,A61K39/395@N,A61K39/395@T,A61K40/11,A61K40/15,A61K40/30,A61K40/31,A61K40/35,A61K40/42,A61K9/08,A61P35/00,A61P35/02,A61P43/00,121,C07K14/52,C07K14/725,C07K14/735,C07K16/28,C07K19/00,C12N15/12,C12N15/62@Z,C12N15/63@Z,C12N5/0783,C12N5/10
Stage: Grant (IP right granted following substantive examination.)
Filing Date: Feb. 22, 2023
Publication Date: April 13, 2023
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication....